Product Recalls: December 11, 2019 – January 15, 2020

Health Letter, February 2020

Note: Never stop taking a drug that appears on the product recall list without first talking to your doctor or pharmacist. Most recalls are limited to a single manufacturer and may not be related to the version of a particular drug you are taking. If a recall does relate to the version of the drug you are taking, you should not stop taking the drug until you discuss an alternative treatment with your doctor or pharmacist.

CLASS I

Mirtazapine tablets, 7.5 or 15 mg, 500-count. Distributed by: Aurobindo Pharma USA, Inc.

CLASS II

Amantadine hydrochloride tablets, 100 mg, 100-count bottle. Manufactured by: Jubilant Generics Ltd.

Gabapentin capsules, 100 mg. Distributed by: Aurobindo Pharma USA.

MYORISAN (isotretinoin) capsules, 20 mg, 30-count (3 x 10 prescription packs) per box. Distributed by: VersaPharm Inc. – An Akorn Company.

Ranitidine tablets or capsules; 150 or 300 mg; 24-, 30-, 60-, 100-, 130-, 180-, 250-, 500- or 1000-count bottles. Manufactured by: AAA Pharmaceutical, Inc.; Amneal Pharmaceuticals, Inc; Appco Pharma LLC; Glenmark Pharmaceuticals Ltd.; or Granules India Limited.

Blisovi Fe 1.5/30 (norethindrone acetate/ethinyl estradiol tablets and ferrous fumarate tablets), 1.5 mg/0.03 mg and 75 mg. Distributed by: Lupin Pharmaceuticals Inc.

For more information about the drug recalls listed above, please visit http://www.accessdata.fda.gov/scripts/ires/index.cfm.

CONSUMER PRODUCTS

For a list of recent recalls of consumer products, please visit the Consumer Product Safety Commission website at http://www.cpsc.gov/en/Recalls/.